NCT04134260 2026-01-14Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE TrialNRG OncologyPhase 3 Recruiting586 enrolled
NCT06660862 2026-01-08Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer.University of ChicagoPhase 4 Not yet recruiting80 enrolled